Myelodysplastic Syndrome (MDS) Treatment Market Share

Market Share of Myelodysplastic Syndrome (MDS) Treatment Industry

In the Myelodysplastic Syndrome (MDS) Treatment Market, major players are focused on expanding their business in different areas by adopting various market strategies, such as partnerships, collaborations, acquisitions, and mergers. Some of the major players operating in the market include AbbVie, Accord Healthcare, Bristol-Myers Squibb, Celgene Corporation, Takeda Pharmaceutical Company Limited, and Novartis AG, among others.

Myelodysplastic Syndrome (MDS) Treatment Market Leaders

1. Takeda Pharmaceutical Company Limited

2. Bristol-Myers Squibb

3. LUPIN

4. Accord Healthcare

5. Otsuka America Pharmaceutical, Inc.

*Disclaimer: Major Players sorted in no particular order